Psychiatric symptoms are considered to be distributed along a continuum, from good mental health to a diagnosable psychiatric disorder. In the case of psychosis, subclinical psychotic experiences, which can include odd behaviors, strange speech, unusual perceptual experiences and social/emotional withdrawal, are often referred to as schizotypy. Research examining schizotypal traits in non-clinical populations is rapidly expanding. The exploration of schizotypy allows us to identify areas of overlap with psychiatric disorders (schizophrenia and related disorders) at genetic, biological, environmental and psychosocial levels, thus identifying putative risk factors, as well as exploring potentially protective factors. Schizotypy is also a valuable model for exploring cognition as performance is not confounded by issues often present in schizophrenia samples, such as long-term antipsychotic medication usage, social isolation, and recurrent hospitalizations. Investigating cognition is a particularly important area of research as cognitive symptoms in schizophrenia, such as impaired attention, reduced memory and difficulties with executive functions, are a core feature of schizophrenia and strongly related to quality of life and functional outcomes, yet generally respond poorly to current treatment options. The aim of this special Research Topic is to explore the relationship between cognition, schizotypy and the schizophrenia spectrum. The articles in this e-book draw on a variety of perspectives and represent an interesting array of opinions, reviews and empirical studies that begin to answer questions about the similarities and overlaps between schizotypy and schizophrenia spectrum disorders, contributing to our understanding of potential risk factors. Equally important is research that highlights differences between schizotypy and schizophrenia spectrum disorders that may enhance our understanding of potentially protective or adaptive features of schizotypy. Collectively, these articles highlight the exploratory potential of the study of schizotypy, particularly in relation to better understanding cognition across the schizophrenia spectrum.

Psychiatric symptoms are considered to be distributed along a continuum, from mental health to a diagnosable psychiatric disorder. In the case of psychosis, subclinical psychotic experiences (which can include odd behaviours, strange speech, unusual perceptual experiences and social anhedonia) are often referred to as schizotypy. Research examining schizotypal traits in non-clinical populations is rapidly expanding. The exploration of schizotypy may help elucidate factors related to the predisposition to psychiatric disorders (schizophrenia and related disorders). Schizotypy is also a valuable model for exploring cognition as performance is not confounded by issues often present in schizophrenia samples, such as long-term antipsychotic medication usage, social isolation, and recurrent hospitalizations (Jahshan and Sergi, 2007). This is particularly important as cognitive symptoms in schizophrenia are strongly related to quality of life and functional outcomes, yet generally respond poorly to current treatment options. In this Research Topic, we welcome contributions that examine the relationship between cognition and the schizophrenia spectrum. Contributions can be either reviews of recent, relevant literature or experimental studies exploring the contribution of environmental, genetic and other biological factors associated with cognition and schizotypy. While some people with high levels of schizotypy exhibit adaptive strengths (such as creativity) and high levels of subjective well being (Goulding, 2004); other people with high levels of schizotypy who also possess other aetiological risk factors are considered to be at high risk for developing schizophrenia. Further insights into underlying protective factors (such as genetic, epigenetic, environmental, or other personality factors) are also welcomed in this edition. It is particularly important to determine factors that may protect some people with high levels of schizotypy from developing a psychotic disorder.

A versatile reference text for developing and applying clinical psychopathology skills Designed to serve as a trusted desktop reference on mental disorders seen across the lifespan for mental health professionals at all levels of experience, Diagnosis and Treatment of Mental Disorders Across the Lifespan, Second Edition expertly covers etiology, clinical presentation, intake and interviewing, diagnosis, and treatment of a wide range of DSM disorders at all developmental stages. Unlike other references, this book takes a lifespan approach that allows readers to develop the clinical skills necessary to respond to mental health concerns in a patient-centered manner. Introductory and advanced features support clinicians at every stage of their careers and help students develop their skills and understanding. Authors Woo and Keatinge combine a review of cutting edge and state-of-the-art findings on diagnosis and treatment with the tools for diagnosing and treating a wide range of mental disorders across the lifespan. . This second edition incorporates the following changes: Fully updated to reflect the DSM-5 Chapters have been reorganized to more closely follow the structure of the DSM-5 Cultural and diversity considerations have been expanded and integrated throughout the book A new integrative model for treatment planning Expanded discussion of rapport building skills and facilitating active engagement Identity issues and the fit between client and intervention model has been added to the case conceptualization model Mental health disorders affect patients of all ages, and the skilled clinician understands that there are no one-size-fits-all treatments. Diagnosis and Treatment of Mental Disorders Across the Lifespan, Second Edition will instruct clinicians and students in psychopathology for every life stage. Praise for the first edition: Reviews This handbook, Diagnosis and Treatment of Mental Disorders Across the Lifespan, comprehensively integrates best practices necessary for clinicians who deal with a wide range of mental disorders across the continuum of development in a practical, applied, and accessible manner. One of the unique aspects of the book is the length to which the authors go to ensure that the up-to-date information contained in the book is practical, user-friendly, and accessible to beginners in clinical practice

One of the first major theoretical reviews of schizophrenia since the publication of the 5th edition of the APA’s Diagnostic and Statistical Manual, the DSM-5, this volume is a landmark in the history of schizophrenia research. It assembles recent groundbreaking developments in research on schizophrenia and reaffirms its central place in the mental health research agenda. Significantly, this volume reflects the paradigmatic shift in schizophrenia research applied in parallel to new approaches in psychiatric diagnosis. New models and findings from across disciplines in recent years reflect a new and greater understanding of the workings of the brain, which, in turn, helps develop our knowledge of the neuro and psychological processes in schizophrenia. Consequently, this volume illustrates a historical convergence of psychology, psychopathology and the neurosciences in schizophrenia. World-renowned leaders of the schizophrenia research community in fields such as neuroscience, p sychiatry, neuropsychology, and clinical psychology offer clear suggestions for further advances in psychological and medical interventions, assessment, prevention strategies, and research. And in keeping with other titles in the Nebraska Symposium on Motivation series, these papers are noteworthy for their depth of detail, scientific rigor, and clinical relevance. Included among the topics: Cognitive organization as a dimension of individual differences and psychopathology. Neurodevelopmental genomic strategies in the study of the psychosis spectrum. Multimodal brain and behavior indices of psychosis risk. The NIMH Research Domain Criteria Project: new approaches to classifying psychotic spectrum disorders. The Neuropsychopathology of Schizophrenia is one of the most forward-thinking and engaging treatments of the field in recent years, and is an i ndispensable text for all researchers, academics, and clinicians who treat or study mental illness, especially psychiatrists, psychologists, mental health practitioners, and neuroscientists specializing in schizophrenia.

Clinical staging is a solution to transform psychiatric diagnosis and improve mental health outcomes.

The Year Book of Psychiatry and Applied Mental Health brings you abstracts of the articles that reported the year's breakthrough developments in psychiatry and mental health, carefully selected from more than 300 journals worldwide. Expert commentaries evaluate the clinical importance of each article and discuss its application to your practice. There's no faster or easier way to stay informed! Annual topics feature the latest information on biological psychiatry, alcohol and substance-related disorders, psychiatry and the law, psychotherapy, and clinical psychiatry.

The book brings together into a single text the interrelated but different research efforts to translate the current evidence on risk and outcome of severe mental disorders into a preventive perspective. The book also introduces a holistic approach to prevention in mental health, by combining biological, psychological and environmental evidence that attempts to blunt the risk and reduce the number of individuals with mental health vulnerabilities who eventually progress to the manifestation of a severe mental disorder. Finally, the book wants also to highlight the possibility to overcome the single disorder-oriented preventive approach in an attempt to intercept a wider at-risk youth population and explore clinical research areas underperformed where future efforts will have to concentrate. Mental health problems have their peak of incidence during the transition from childhood to young adulthood, interesting up to 20% adolescents. Half of those eventually developing such difficulties experience clinically relevant mental distress by the age of 14. Even more importantly, the symptomatic onset is generally anticipated by non-specific warning signs of psychosocial impairment potentially evolving in any severe mental disorder. This is of crucial importance, as almost one in two health problems contributing to the global disease burden across the 0-25 age span is a mental disorder. The search for preventive strategies among youth has developed over the past 2-3 decades, invigorated by a rethinking of mental disorders’ ineluctable prodromal phase into a period where the trajectory of illness can be slowed down, blunted, or even halted. The paradigms for implementing preventing approaches in mental health have often developed independent of each other. This book aims at summarizing the available evidence and make a step towards a more mature vision of the potentialities of promotion and prevention in mental health.